search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
paromomycin


apramycin


Check Huvepharma® Product Range against Escherichia coli


Another microscopic image: PCV3 virus photographed in a pig’s spleen.


detection should not have any public health implications.


PCV3 in animals other than pigs Last but not least – does the virus also occur outside swine or wild boar, that is, in wildlife species in Spain? The answer to that question appears to be “no.” The reason for the research, however, was the fact that PCV3 DNA had been confirmed in Italian wild ruminants and relat- ed haematophagous ectoparasites. To figure out whether in Spain the situation was similar, the CReSA-IRTA team in coop- eration with the Polish National Veterinary Institute and the Universitat Autònoma de Barcelona investigated samples from a range of animals such as hunted red deer, rabbits and hares. They concluded: “The present study indicated that wild ruminants and lagomorphs do not play a significant role in the epidemiology of PCV3 in Spain, suggesting that these in- fections may be caused by eventual spillover events.”


Next steps: Pathogenesis of PCV3 All in all, even though the effect and impact of the virus can- not be compared to PCV2, there is some reason to keep an eye on it. Dr Sibila said, “In most cases, PCV3 infection will be subclinical (of unknown impact). However, in our opinion, it is worthwhile including PCV3 in the potential list of viruses causing an increase of the normal rate of stillborn and mummified foetuses and/or potential cause of pre- and post-weaning disorders.” The team will continue to investigate the virus. Dr Sibila said, “Now we are working on the pathogenesis of PCV3 infection. Hopefully, we will be able to share the results obtained in the next ESPHM.”


The first paper described in this article was an oral presentation at ESPHM 2020+1; it was carried out by V. Saporiti, F. Klaumann, M. Sibila and J. Segalés, CReSA-IRTA; S. Martorell and M. Balasch, Zoetis; T.F. Cruz, São Paulo State University, Brazil. J. Segalés is also attached to the Universitat Autònoma de Barcelona, Spain.


▶ PIG PROGRESS | Volume 37, No. 7, 2021 17


∙ Highly effective against Colibacillosis in suckling and weaner pigs


∙ Valuable treatment with consistent efficacy over many years


∙ The alternative treatment option for antimicrobials under restriction


www.huvepharma.com


PHOTO: CRESA-IRTA


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44